Literature DB >> 14667261

Spontaneous conversion of atrial fibrillation in the setting of biventricular pacing.

Julia H Indik1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14667261     DOI： 10.1097/01.crd.0000099620.26844.2a

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN： 1061-5377            Impact factor:   2.644


× No keyword cloud information.
  7 in total

1.  Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm.

Authors:  P Kiès; C Leclercq; G B Bleeker; C Crocq; S G Molhoek; C Poulain; L van Erven; M Bootsma; K Zeppenfeld; E E van der Wall; J-C Daubert; M J Schalij; J J Bax
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 2.  [Cardiac resynchronization therapy and arrhythmias].

Authors:  D Böcker; R Gradaus
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2005-03

3.  [Cardiac resynchronization therapy in patients with permanent atrial fibrillation--with or without atrial lead?].

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-12

Review 4.  CRT-D therapy in patients with left ventricular dysfunction and atrial fibrillation.

Authors:  Frank Pelosi; Fred Morady
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

Review 5.  Cardiac Resynchronization Therapy and Atrial Fibrillation.

Authors:  Ganesh S Kamath; Jonathan S Steinberg
Journal:  J Atr Fibrillation       Date:  2011-09-30

Review 6.  Resynchronization therapy in the context of atrial fibrillation: benefits and limitations.

Authors:  Uta C Hoppe
Journal:  J Interv Card Electrophysiol       Date:  2007-04-21       Impact factor: 1.900

7.  Effect of cardiac resynchronization therapy on conversion of persistent atrial fibrillation to sinus rhythm.

Authors:  Melanie Hauck; Alexander Bauer; Frederik Voss; Hugo A Katus; Ruediger Becker
Journal:  Clin Res Cardiol       Date:  2008-11-25       Impact factor: 5.460
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.